用生成性人工智能重新想象癌症护理:大型语言模型的承诺
Ji-Eun Irene Yum1, Syed Arsalan Ahmed Naqvi1, Ben Zhou2
1Mayo Clinic, Phoenix, AZ.
JCO clinical cancer informatics
|December 1, 2025
概括
大型语言模型 (LLM) 通过分析广泛的患者数据,为癌症护理提供了新的机会. 未来的研究应该关注患者的观点和安全整合的现实世界测试.
科学领域:
- 人工智能在医学中的应用
- 瘤学 信息学 信息学
背景情况:
- 大型语言模型 (LLM) 展示了先进的自然语言处理能力,开辟了医疗保健领域的新途径.
- 癌症患者的旅程产生了丰富的纵向数据,非常适合LLM分析.
研究的目的:
- 审查LLM的基本概念,包括架构,培训和优化.
- 为患者,临床医生,研究人员和学习者探索LLM在瘤学的应用.
- 解决与LLM在癌症护理中的实施相关的局限性和风险.
主要方法:
- 对LLM基础的审查:定义,架构,培训和优化技术 (提示工程,检索增强生成).
- 探索LLMs的多机构框架.
- 综合目前关于LLM在瘤学的好处和风险的研究.
- 确定未来的研究方向.
主要成果:
- 由于广泛的患者数据,LLM可以在各种NLP任务中概括,在瘤学中具有显著的潜力.
- 潜在的好处涵盖患者,瘤学家,研究人员和学习者,增强癌症护理的各个方面.
- 确定的风险包括模型幻觉,数据偏差,患者隐私问题和潜在的临床医生失业.
结论:
- 在转变瘤学方面,LLM显著有前途,但仔细考虑风险至关重要.
- 未来的研究必须优先考虑患者的观点,临床基准,现实世界的验证,以及对LLM推理的更深入理解.
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Mouse Models of Cancer Study
6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


